Raymond James Financial Services Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$444K	Sell	67,401 -22,579	-25%	-$149K	﹤0.01%	2702
2024 Q2	$675K	Buy	89,980 +25,046	+39%	+$188K	﹤0.01%	2330
2024 Q1	$647K	Buy	+64,934	New	+$647K	﹤0.01%	2331